GeneDx Holdings Corp.
WGS
$86.48
$0.610.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.77% | 18.12% | 24.51% | 46.64% | 44.16% |
| Total Other Revenue | -1.47% | -29.57% | 156.44% | 691.91% | 141.12% |
| Total Revenue | 11.44% | 17.38% | 26.50% | 51.86% | 45.63% |
| Cost of Revenue | 13.73% | 18.87% | 24.74% | 10.94% | 15.34% |
| Gross Profit | 10.41% | 16.65% | 27.29% | 76.71% | 65.07% |
| SG&A Expenses | 62.25% | 47.85% | 58.39% | 54.63% | 9.93% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.66% | 40.12% | 54.11% | 41.76% | 15.59% |
| Operating Income | -294.29% | -475.35% | -245.70% | 58.18% | 184.70% |
| Income Before Tax | -272.85% | -926.29% | -436.72% | 11.62% | 135.97% |
| Income Tax Expenses | -110.57% | 100.67% | -2,250.00% | 625.53% | -29.47% |
| Earnings from Continuing Operations | -264.12% | -869.77% | -424.86% | 8.14% | 137.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -264.12% | -869.77% | -424.86% | 8.14% | 137.05% |
| EBIT | -294.29% | -475.35% | -245.70% | 58.18% | 184.70% |
| EBITDA | -170.58% | -1,819.17% | -150.87% | 274.69% | 382.62% |
| EPS Basic | -257.88% | -830.34% | -410.73% | 13.59% | 134.51% |
| Normalized Basic EPS | -265.84% | -287.70% | -183.55% | 44.94% | 133.50% |
| EPS Diluted | -266.67% | -830.34% | -410.73% | 13.59% | 132.73% |
| Normalized Diluted EPS | -272.65% | -287.70% | -183.55% | 44.94% | 132.18% |
| Average Basic Shares Outstanding | 3.96% | 4.22% | 4.56% | 6.28% | 7.37% |
| Average Diluted Shares Outstanding | -0.15% | 4.22% | 4.56% | 6.28% | 11.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |